@manishv Usually I am pretty adept and not taking the dt bait.....but the pedestrian commentary your provide is bereft of any meaningful comprehension of:
1) the complexity of bringing a novel class of therapy to market 2) timeframes associated with bringing a novel therapeutic to market 3) the increase in clinical awareness/understanding required to support market penetration 4) supply chain logistics 5) the intrinsic value of an the IP moat that characterise MSBs value proposition 6) valuation of phase 3 studies and associated clinical insights to support future commercialisation of block buster indications for CLBP and CHF
MSB is not a mining company-perhaps day trading CHN for a pip is time better spent rather than clogging up these boards with inane commentary whilst purporting to know best
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)